229 related articles for article (PubMed ID: 23394117)
1. Working memory- and anxiety-related behavioral effects of repeated nicotine as a stressor: the role of cannabinoid receptors.
Hayase T
BMC Neurosci; 2013 Feb; 14():20. PubMed ID: 23394117
[TBL] [Abstract][Full Text] [Related]
2. Chronologically overlapping occurrences of nicotine-induced anxiety- and depression-related behavioral symptoms: effects of anxiolytic and cannabinoid drugs.
Hayase T
BMC Neurosci; 2007 Sep; 8():76. PubMed ID: 17877812
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of TRPV1 receptor ligands against nicotine-induced depression-like behaviors.
Hayase T
BMC Pharmacol; 2011 Jul; 11():6. PubMed ID: 21767384
[TBL] [Abstract][Full Text] [Related]
4. Putative Epigenetic Involvement of the Endocannabinoid System in Anxiety- and Depression-Related Behaviors Caused by Nicotine as a Stressor.
Hayase T
PLoS One; 2016; 11(7):e0158950. PubMed ID: 27404492
[TBL] [Abstract][Full Text] [Related]
5. Nicotine (NC)-induced "depressive" behavioral symptoms and effects of antidepressants including cannabinoids (CBs).
Hayase T
J Toxicol Sci; 2008 Dec; 33(5):555-64. PubMed ID: 19043277
[TBL] [Abstract][Full Text] [Related]
6. Depression-related anhedonic behaviors caused by immobilization stress: a comparison with nicotine-induced depression-like behavioral alterations and effects of nicotine and/or "antidepressant" drugs.
Hayase T
J Toxicol Sci; 2011 Jan; 36(1):31-41. PubMed ID: 21297339
[TBL] [Abstract][Full Text] [Related]
7. Anxiogenic profile of AM-251, a selective cannabinoid CB1 receptor antagonist, in plus-maze-naïve and plus-maze-experienced mice.
Rodgers RJ; Evans PM; Murphy A
Behav Pharmacol; 2005 Sep; 16(5-6):405-13. PubMed ID: 16148445
[TBL] [Abstract][Full Text] [Related]
8. Differential role of the basolateral amygdala 5-HT3 and 5-HT4 serotonin receptors upon ACPA-induced anxiolytic-like behaviors and emotional memory deficit in mice.
Chegini HR; Nasehi M; Zarrindast MR
Behav Brain Res; 2014 Mar; 261():114-26. PubMed ID: 24333573
[TBL] [Abstract][Full Text] [Related]
9. Hippocampal CB(1) receptors mediate the memory impairing effects of Delta(9)-tetrahydrocannabinol.
Wise LE; Thorpe AJ; Lichtman AH
Neuropsychopharmacology; 2009 Aug; 34(9):2072-80. PubMed ID: 19322169
[TBL] [Abstract][Full Text] [Related]
10. Cannabinoid receptor ligands suppress memory-related effects of nicotine in the elevated plus maze test in mice.
Biala G; Kruk M
Behav Brain Res; 2008 Oct; 192(2):198-202. PubMed ID: 18501975
[TBL] [Abstract][Full Text] [Related]
11. Anxiety-like effects of SR141716-precipitated delta9-tetrahydrocannabinol withdrawal in mice in the elevated plus-maze.
Huang P; Liu-Chen LY; Kirby LG
Neurosci Lett; 2010 May; 475(3):165-8. PubMed ID: 20363293
[TBL] [Abstract][Full Text] [Related]
12. SLV330, a cannabinoid CB1 receptor antagonist, ameliorates deficits in the T-maze, object recognition and Social Recognition Tasks in rodents.
de Bruin NM; Prickaerts J; Lange JH; Akkerman S; Andriambeloson E; de Haan M; Wijnen J; van Drimmelen M; Hissink E; Heijink L; Kruse CG
Neurobiol Learn Mem; 2010 May; 93(4):522-31. PubMed ID: 20132903
[TBL] [Abstract][Full Text] [Related]
13. Persistent anxiogenic effects of a single or repeated doses of cocaine and methamphetamine: interactions with endogenous cannabinoid receptor ligands.
Hayase T; Yamamoto Y; Yamamoto K
Behav Pharmacol; 2005 Sep; 16(5-6):395-404. PubMed ID: 16148444
[TBL] [Abstract][Full Text] [Related]
14. The Influence of the CB1 Receptor Ligands on the Schizophrenia-Like Effects in Mice Induced by MK-801.
Kruk-Slomka M; Budzynska B; Slomka T; Banaszkiewicz I; Biala G
Neurotox Res; 2016 Nov; 30(4):658-676. PubMed ID: 27577742
[TBL] [Abstract][Full Text] [Related]
15. A cannabinoid CB(1) receptor antagonist ameliorates impairment of recognition memory on withdrawal from MDMA (Ecstasy).
Nawata Y; Hiranita T; Yamamoto T
Neuropsychopharmacology; 2010 Jan; 35(2):515-20. PubMed ID: 19829291
[TBL] [Abstract][Full Text] [Related]
16. Adolescent exposure to nicotine and/or the cannabinoid agonist CP 55,940 induces gender-dependent long-lasting memory impairments and changes in brain nicotinic and CB(1) cannabinoid receptors.
Mateos B; Borcel E; Loriga R; Luesu W; Bini V; Llorente R; Castelli MP; Viveros MP
J Psychopharmacol; 2011 Dec; 25(12):1676-90. PubMed ID: 20562169
[TBL] [Abstract][Full Text] [Related]
17. Modulation of anxiety by acute blockade and genetic deletion of the CB(1) cannabinoid receptor in mice together with biogenic amine changes in the forebrain.
Thiemann G; Watt CA; Ledent C; Molleman A; Hasenöhrl RU
Behav Brain Res; 2009 Jun; 200(1):60-7. PubMed ID: 19162082
[TBL] [Abstract][Full Text] [Related]
18. Effects of the cannabinoid receptor ligands on anxiety-related effects of d-amphetamine and nicotine in the mouse elevated plus maze test.
Biala G; Kruk M; Budzynska B
J Physiol Pharmacol; 2009 Jun; 60(2):113-22. PubMed ID: 19617654
[TBL] [Abstract][Full Text] [Related]
19. Impacts of cannabinoid receptor ligands on nicotine- and chronic mild stress-induced cognitive and depression-like effects in mice.
Pekala K; Michalak A; Kruk-Slomka M; Budzynska B; Biala G
Behav Brain Res; 2018 Jul; 347():167-174. PubMed ID: 29551733
[TBL] [Abstract][Full Text] [Related]
20. The cannabinoid antagonist SR141716A facilitates memory acquisition and consolidation in the mouse elevated T-maze.
Takahashi RN; Pamplona FA; Fernandes MS
Neurosci Lett; 2005 Jun; 380(3):270-5. PubMed ID: 15862900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
